Summary
Gateway Health Alliances has announced the publication of updated clinical results showing that its patented botanical extracts, Dyglomera (Dichrostachys glomerata) and CQR-300 (Cissus quadrangularis), significantly increased natural GLP-1 levels by inhibiting DPP-4 activity.
Published in the peer-…
Source: Nutraceutical Business Review
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
